Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Gross Margin (2018 - 2025)

Selectis Health's Gross Margin history spans 8 years, with the latest figure at 21.41% for Q3 2025.

  • For Q3 2025, Gross Margin fell 298.0% year-over-year to 21.41%; the TTM value through Sep 2025 reached 22.63%, up 158.0%, while the annual FY2024 figure was 23.13%, 843.0% up from the prior year.
  • Gross Margin for Q3 2025 was 21.41% at Selectis Health, down from 21.89% in the prior quarter.
  • Across five years, Gross Margin topped out at 39.69% in Q3 2021 and bottomed at 11.41% in Q1 2023.
  • The 5-year median for Gross Margin is 22.57% (2021), against an average of 23.46%.
  • The largest annual shift saw Gross Margin plummeted -2570bps in 2021 before it skyrocketed 1635bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 13.08% in 2021, then soared by 51bps to 19.75% in 2022, then fell by -20bps to 15.87% in 2023, then skyrocketed by 53bps to 24.34% in 2024, then dropped by -12bps to 21.41% in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Gross Margin are 21.41% (Q3 2025), 21.89% (Q2 2025), and 22.94% (Q1 2025).